Lupin Metformin Recall Lawsuit

What’s the Problem?

This recall affects Lupin Metformin Hydrochloride Extended-Release Tablets USP (generic equivalent of Fortamet), 500mg, lot G901203, according to a Recall Notice by the U.S. Food & Drug Administration (FDA).

Lupin Pharmaceuticals issued the recall after FDA testing detected NDMA levels that exceeded the Acceptable Daily Intake Limit (ADI) of 96ng/day.

Animal studies have found that high doses of NDMA may cause liver, lung, and kidney cancer. The World Health Organization (WHO) says it can also lead to gastric or colorectal cancer.

If you were prescribed any metformin that is included in this recall, you should contact Lupin Pharmaceuticals for information about a return/replacement. Anyone concerned about a potential adverse reaction to NDMA in metformin should consult their physician.

This recall began on June 11, 2020.

Do I Have a Lupin Metformin Recall Lawsuit?

The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Lupin Metformin Recall Lawsuits. We are handling individual litigation nationwide and currently accepting new injury and death cases in all 50 states.

If you or a loved one was diagnosed with cancer after taking recalled metformin, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.